• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球前列腺癌死亡率的基于模型的模式。

Model-based patterns in prostate cancer mortality worldwide.

机构信息

Institute of Public Health of the University of Porto, Porto, Portugal.

出版信息

Br J Cancer. 2013 Jun 11;108(11):2354-66. doi: 10.1038/bjc.2013.217. Epub 2013 May 9.

DOI:10.1038/bjc.2013.217
PMID:23660943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3681014/
Abstract

BACKGROUND

Prostate cancer mortality has been decreasing in several high income countries and previous studies analysed the trends mostly according to geographical criteria. We aimed to identify patterns in the time trends of prostate cancer mortality across countries using a model-based approach.

METHODS

Model-based clustering was used to identify patterns of variation in prostate cancer mortality (1980-2010) across 37 European, five non-European high-income countries and four leading emerging economies. We characterised the patterns observed regarding the geographical distribution and gross national income of the countries, as well as the trends observed in mortality/incidence ratios.

RESULTS

We identified three clusters of countries with similar variation in prostate cancer mortality: pattern 1 ('no mortality decline'), characterised by a continued increase throughout the whole period; patterns 2 ('later mortality decline') and 3 ('earlier mortality decline') depict mortality declines, starting in the late and early 1990s, respectively. These clusters are also homogeneous regarding the variation in the prostate cancer mortality/incidence ratios, while are heterogeneous with reference to the geographical region of the countries and distribution of the gross national income.

CONCLUSION

We provide a general model for the description and interpretation of the trends in prostate cancer mortality worldwide, based on three main patterns.

摘要

背景

在一些高收入国家,前列腺癌死亡率一直在下降,先前的研究主要根据地理标准分析这些趋势。我们旨在使用基于模型的方法确定各国前列腺癌死亡率随时间变化的模式。

方法

使用基于模型的聚类方法,分析了 37 个欧洲国家、5 个非欧洲高收入国家和 4 个主要新兴经济体的前列腺癌死亡率(1980-2010 年)的变化模式。我们对观察到的模式进行了描述,包括国家的地理分布和国民总收入,以及死亡率/发病率比值的变化趋势。

结果

我们确定了三个具有相似前列腺癌死亡率变化模式的国家集群:模式 1(“死亡率无下降”),整个时期持续上升;模式 2(“死亡率后期下降”)和模式 3(“死亡率早期下降”)分别描绘了 90 年代末和 90 年代初开始的死亡率下降趋势。这些集群在前列腺癌死亡率/发病率比值的变化方面是同质的,而在国家的地理区域和国民总收入的分布方面则是异质的。

结论

我们根据三个主要模式,为描述和解释全球前列腺癌死亡率的变化趋势提供了一个通用模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/1e5d2dea8050/bjc2013217fa3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/f38bcc682082/bjc2013217f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/62291c8a7f7e/bjc2013217f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/299a0af8fce9/bjc2013217f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/2e14681a7bd8/bjc2013217f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/85afd8cc67a9/bjc2013217f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/d9f3c03f8ec7/bjc2013217fa1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/45af28e3fee2/bjc2013217fa2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/1e5d2dea8050/bjc2013217fa3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/f38bcc682082/bjc2013217f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/62291c8a7f7e/bjc2013217f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/299a0af8fce9/bjc2013217f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/2e14681a7bd8/bjc2013217f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/85afd8cc67a9/bjc2013217f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/d9f3c03f8ec7/bjc2013217fa1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/45af28e3fee2/bjc2013217fa2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36f/3681014/1e5d2dea8050/bjc2013217fa3a.jpg

相似文献

1
Model-based patterns in prostate cancer mortality worldwide.全球前列腺癌死亡率的基于模型的模式。
Br J Cancer. 2013 Jun 11;108(11):2354-66. doi: 10.1038/bjc.2013.217. Epub 2013 May 9.
2
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.前列腺癌发病率、生存率、患病率和死亡率的模式与趋势。第一部分:国际比较。
BJU Int. 2002 Jul;90(2):162-73. doi: 10.1046/j.1464-410x.2002.2822.x.
3
Patterns of breast cancer mortality trends in Europe.欧洲乳腺癌死亡率趋势的模式。
Breast. 2013 Jun;22(3):244-53. doi: 10.1016/j.breast.2013.02.007. Epub 2013 Mar 9.
4
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.全球前列腺癌发病率和死亡率:36 个国家时间模式和趋势分析。
Eur Urol. 2016 Nov;70(5):862-874. doi: 10.1016/j.eururo.2016.05.043. Epub 2016 Jun 8.
5
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.近期全球前列腺癌发病率和死亡率模式。
Eur Urol. 2020 Jan;77(1):38-52. doi: 10.1016/j.eururo.2019.08.005. Epub 2019 Sep 5.
6
Worldwide patterns of ischemic heart disease mortality from 1980 to 2010.全球 1980 至 2010 年缺血性心脏病死亡率的变化趋势。
Int J Cardiol. 2014 Jan 1;170(3):309-14. doi: 10.1016/j.ijcard.2013.11.004. Epub 2013 Nov 13.
7
Prostate cancer incidence and mortality trends among elderly and adult Europeans.欧洲老年人和成年人前列腺癌的发病率及死亡率趋势
Crit Rev Oncol Hematol. 2000 Aug;35(2):133-44. doi: 10.1016/s1040-8428(99)00067-0.
8
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
9
Bayesian clustering of 109 worldwide countries according to the trend of prostate cancer mortality rates from 1990 to 2019.根据 1990 年至 2019 年前列腺癌死亡率的趋势对全球 109 个国家进行贝叶斯聚类。
PLoS One. 2023 Aug 14;18(8):e0290110. doi: 10.1371/journal.pone.0290110. eCollection 2023.
10
[Trends in prostate cancer mortality in Portugal (1980-2006)].[葡萄牙前列腺癌死亡率趋势(1980 - 2006年)]
Acta Med Port. 2011 Jul-Aug;24(4):499-504. Epub 2011 Dec 12.

引用本文的文献

1
Cognitive decline in patients with prostate cancer: study protocol of a prospective cohort, NEON-PC.前列腺癌患者的认知功能减退:前瞻性队列研究NEON-PC的研究方案
BMJ Open. 2021 Feb 15;11(2):e043844. doi: 10.1136/bmjopen-2020-043844.
2
Cancer Mortality in the Niger Delta Region of Nigeria: A Case Study of the University of Port Harcourt Teaching Hospital.尼日利亚尼日尔三角洲地区的癌症死亡率:以哈科特港大学教学医院为例
Niger Med J. 2019 Sep-Oct;60(5):262-267. doi: 10.4103/nmj.NMJ_51_19. Epub 2019 Nov 26.
3
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.

本文引用的文献

1
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.2008 年全球癌症负担:12 个世界区域按失能调整生命年衡量的系统分析。
Lancet. 2012 Nov 24;380(9856):1840-50. doi: 10.1016/S0140-6736(12)60919-2. Epub 2012 Oct 16.
2
Radical prostatectomy versus observation for localized prostate cancer.根治性前列腺切除术与观察等待治疗局限性前列腺癌的比较。
N Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162.
3
International variation in prostate cancer incidence and mortality rates.
ABO/Rh血型不影响接受根治性前列腺切除术患者的临床病理肿瘤特征或肿瘤学结局。
Front Surg. 2017 Dec 18;4:75. doi: 10.3389/fsurg.2017.00075. eCollection 2017.
4
Radiation treatment of prostate cancers - the contemporary role of modern brachytherapy techniques.前列腺癌的放射治疗——现代近距离放射治疗技术的当代作用。
J Contemp Brachytherapy. 2017 Oct;9(5):391-392. doi: 10.5114/jcb.2017.71034. Epub 2017 Oct 30.
5
An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?澳大利亚、英国、加拿大和美国前列腺癌趋势研究:澳大利亚的死亡率是否过高?
World J Urol. 2015 Nov;33(11):1677-87. doi: 10.1007/s00345-015-1514-7. Epub 2015 Feb 20.
6
Health status, use of healthcare, and socio-economic implications of cancer survivorship in Portugal: results from the Fourth National Health Survey.葡萄牙癌症幸存者的健康状况、医疗保健利用情况及社会经济影响:第四次全国健康调查结果
J Cancer Surviv. 2014 Dec;8(4):611-7. doi: 10.1007/s11764-014-0370-6. Epub 2014 Jun 6.
前列腺癌发病率和死亡率的国际差异。
Eur Urol. 2012 Jun;61(6):1079-92. doi: 10.1016/j.eururo.2012.02.054. Epub 2012 Mar 8.
4
Prostate-cancer mortality at 11 years of follow-up.前列腺癌死亡率随访 11 年后。
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
5
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.随机前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中的前列腺癌筛查:13 年随访后的死亡率结果。
J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.
6
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.联合雄激素剥夺疗法和放射治疗局部晚期前列腺癌:一项随机、3 期试验。
Lancet. 2011 Dec 17;378(9809):2104-11. doi: 10.1016/S0140-6736(11)61095-7. Epub 2011 Nov 2.
7
Radical prostatectomy versus watchful waiting in early prostate cancer.根治性前列腺切除术与早期前列腺癌的观察等待。
N Engl J Med. 2011 May 5;364(18):1708-17. doi: 10.1056/NEJMoa1011967.
8
Trends in mortality from urologic cancers in Europe, 1970-2008.欧洲泌尿系统癌症死亡率趋势,1970-2008 年。
Eur Urol. 2011 Jul;60(1):1-15. doi: 10.1016/j.eururo.2011.03.047. Epub 2011 Apr 5.
9
Prostate cancer incidence and mortality trends in 37 European countries: an overview.37 个欧洲国家的前列腺癌发病率和死亡率趋势:概述。
Eur J Cancer. 2010 Nov;46(17):3040-52. doi: 10.1016/j.ejca.2010.09.013.
10
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.前列腺癌根治术后 III 期辅助放疗与单纯前列腺癌根治术治疗术后前列腺特异性抗原检测不到的 pT3 前列腺癌的比较:ARO 96-02/AUO AP 09/95
J Clin Oncol. 2009 Jun 20;27(18):2924-30. doi: 10.1200/JCO.2008.18.9563. Epub 2009 May 11.